CN105974122A - 一种检测外泌体gpc1蛋白的方法 - Google Patents
一种检测外泌体gpc1蛋白的方法 Download PDFInfo
- Publication number
- CN105974122A CN105974122A CN201610296295.0A CN201610296295A CN105974122A CN 105974122 A CN105974122 A CN 105974122A CN 201610296295 A CN201610296295 A CN 201610296295A CN 105974122 A CN105974122 A CN 105974122A
- Authority
- CN
- China
- Prior art keywords
- antibody
- gpc1
- secreting
- albumen
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 40
- 210000001808 exosome Anatomy 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title description 2
- 108090000623 proteins and genes Proteins 0.000 title description 2
- 239000011324 bead Substances 0.000 claims abstract description 66
- 238000001514 detection method Methods 0.000 claims abstract description 41
- 102100034190 Glypican-1 Human genes 0.000 claims abstract description 34
- 101001070736 Homo sapiens Glypican-1 Proteins 0.000 claims abstract description 34
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 22
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims abstract description 11
- 229960002685 biotin Drugs 0.000 claims abstract description 11
- 235000020958 biotin Nutrition 0.000 claims abstract description 11
- 239000011616 biotin Substances 0.000 claims abstract description 11
- 239000000758 substrate Substances 0.000 claims abstract description 6
- 108010090804 Streptavidin Proteins 0.000 claims abstract description 5
- 230000003248 secreting effect Effects 0.000 claims description 40
- 125000003700 epoxy group Chemical group 0.000 claims description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- 229910019142 PO4 Inorganic materials 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000010452 phosphate Substances 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 3
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 3
- 238000004132 cross linking Methods 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 15
- 238000005516 engineering process Methods 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 3
- 201000011510 cancer Diseases 0.000 abstract description 3
- 238000003745 diagnosis Methods 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 230000004907 flux Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 21
- 230000000694 effects Effects 0.000 description 15
- 238000002965 ELISA Methods 0.000 description 11
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 9
- 229940098773 bovine serum albumin Drugs 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 239000013642 negative control Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 239000000427 antigen Substances 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 210000004881 tumor cell Anatomy 0.000 description 4
- 238000000970 chrono-amperometry Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000004614 tumor growth Effects 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 102000010956 Glypican Human genes 0.000 description 2
- 108050001154 Glypican Proteins 0.000 description 2
- 108050007238 Glypican-1 Proteins 0.000 description 2
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- 206010033128 Ovarian cancer Diseases 0.000 description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000000612 antigen-presenting cell Anatomy 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229940005654 nitrite ion Drugs 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000002331 protein detection Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical group CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 102100027221 CD81 antigen Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101000914479 Homo sapiens CD81 antigen Proteins 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000014102 antigen processing and presentation of exogenous peptide antigen via MHC class I Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000005975 antitumor immune response Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 230000005909 tumor killing Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610296295.0A CN105974122B (zh) | 2016-05-04 | 2016-05-04 | 一种检测外泌体gpc1蛋白的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610296295.0A CN105974122B (zh) | 2016-05-04 | 2016-05-04 | 一种检测外泌体gpc1蛋白的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105974122A true CN105974122A (zh) | 2016-09-28 |
CN105974122B CN105974122B (zh) | 2018-09-28 |
Family
ID=56992683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610296295.0A Active CN105974122B (zh) | 2016-05-04 | 2016-05-04 | 一种检测外泌体gpc1蛋白的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105974122B (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107338306A (zh) * | 2017-07-23 | 2017-11-10 | 嘉兴允英医学检验有限公司 | 一种用于GPC1mRNA表达检测的试剂盒 |
CN108387746A (zh) * | 2018-03-02 | 2018-08-10 | 浙江大学 | 一种捕获外泌体的超顺磁纳米微粒及其制备方法和特异性外泌体发光免疫定量检测试剂盒 |
CN109270267A (zh) * | 2018-11-02 | 2019-01-25 | 上海宝藤生物医药科技股份有限公司 | 用于胰腺癌早期诊断的外泌体cd82蛋白及其检测试剂盒 |
CN109490528A (zh) * | 2017-10-05 | 2019-03-19 | 香港科技大学 | 外泌体分析及癌症诊断方法 |
CN109913417A (zh) * | 2018-12-29 | 2019-06-21 | 复旦大学附属华山医院 | 一种采用快速免疫磁珠法分离脑脊液中不同细胞来源外泌体亚型的方法 |
CN110462064A (zh) * | 2017-04-18 | 2019-11-15 | 深圳华大生命科学研究院 | 基于外泌体核酸进行微生物检测的方法及其应用 |
WO2020012482A1 (en) | 2018-07-11 | 2020-01-16 | Ofek - Eshkolot Research And Development Ltd. | Method and device for detecting extracellular vesicles |
CN111474356A (zh) * | 2020-04-16 | 2020-07-31 | 江西省达臻医疗科技有限公司 | 一种双免疫磁珠分选试剂及其制备方法和在体液外泌体富集中的应用 |
CN111551717A (zh) * | 2020-04-10 | 2020-08-18 | 深圳大学 | 一种基于有机光电化学晶体管的胃泌素释放肽前体传感器及其制备方法与应用 |
CN113607948A (zh) * | 2017-04-10 | 2021-11-05 | 南通大学附属医院 | 检测血清中Glypican-1蛋白含量在评价胰腺癌发生发展和分期判断中的应用 |
CN113866407A (zh) * | 2021-12-01 | 2021-12-31 | 上海思路迪医学检验所有限公司 | 一种外泌体her2蛋白的磁免疫化学发光检测试剂盒 |
WO2022095141A1 (zh) * | 2020-11-09 | 2022-05-12 | 苏州吉玛基因股份有限公司 | 一种gpc1 dna适配体及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1588071A (zh) * | 2004-08-16 | 2005-03-02 | 上海市胸科医院 | 一种酶标记免疫电化学检测方法 |
CN1906307A (zh) * | 2003-11-20 | 2007-01-31 | 圣诺菲·帕斯图尔公司 | 纯化百日咳毒素的方法及其中有用的肽 |
-
2016
- 2016-05-04 CN CN201610296295.0A patent/CN105974122B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1906307A (zh) * | 2003-11-20 | 2007-01-31 | 圣诺菲·帕斯图尔公司 | 纯化百日咳毒素的方法及其中有用的肽 |
CN1588071A (zh) * | 2004-08-16 | 2005-03-02 | 上海市胸科医院 | 一种酶标记免疫电化学检测方法 |
Non-Patent Citations (2)
Title |
---|
SONIA A. MELO ET AL.: "Glypican-1 identifies cancer exosomes and detects early pancreatic cancer", 《NATURE》 * |
V. RUIZ-VALDEPEÑAS MONTIEL ET AL.: "Sensitive and selective magnetoimmunosensing platform for determination of the food allergen Ara h 1", 《ANALYTICA CHIMICA ACTA》 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113607948A (zh) * | 2017-04-10 | 2021-11-05 | 南通大学附属医院 | 检测血清中Glypican-1蛋白含量在评价胰腺癌发生发展和分期判断中的应用 |
CN110462064A (zh) * | 2017-04-18 | 2019-11-15 | 深圳华大生命科学研究院 | 基于外泌体核酸进行微生物检测的方法及其应用 |
CN107338306A (zh) * | 2017-07-23 | 2017-11-10 | 嘉兴允英医学检验有限公司 | 一种用于GPC1mRNA表达检测的试剂盒 |
CN109490528A (zh) * | 2017-10-05 | 2019-03-19 | 香港科技大学 | 外泌体分析及癌症诊断方法 |
WO2019068269A1 (en) * | 2017-10-05 | 2019-04-11 | The Hong Kong University Of Science And Technology | ANALYSIS OF EXOSOMES AND DIAGNOSTIC METHODS FOR CANCER |
CN108387746A (zh) * | 2018-03-02 | 2018-08-10 | 浙江大学 | 一种捕获外泌体的超顺磁纳米微粒及其制备方法和特异性外泌体发光免疫定量检测试剂盒 |
WO2020012482A1 (en) | 2018-07-11 | 2020-01-16 | Ofek - Eshkolot Research And Development Ltd. | Method and device for detecting extracellular vesicles |
US11513074B2 (en) | 2018-07-11 | 2022-11-29 | Ofek—Eshkolot Research And Development Ltd. | Method and device for detecting extracellular vesicles |
CN109270267A (zh) * | 2018-11-02 | 2019-01-25 | 上海宝藤生物医药科技股份有限公司 | 用于胰腺癌早期诊断的外泌体cd82蛋白及其检测试剂盒 |
CN109913417A (zh) * | 2018-12-29 | 2019-06-21 | 复旦大学附属华山医院 | 一种采用快速免疫磁珠法分离脑脊液中不同细胞来源外泌体亚型的方法 |
CN111551717A (zh) * | 2020-04-10 | 2020-08-18 | 深圳大学 | 一种基于有机光电化学晶体管的胃泌素释放肽前体传感器及其制备方法与应用 |
CN111551717B (zh) * | 2020-04-10 | 2023-04-07 | 深圳大学 | 一种基于有机光电化学晶体管的胃泌素释放肽前体传感器及其制备方法与应用 |
CN111474356A (zh) * | 2020-04-16 | 2020-07-31 | 江西省达臻医疗科技有限公司 | 一种双免疫磁珠分选试剂及其制备方法和在体液外泌体富集中的应用 |
WO2022095141A1 (zh) * | 2020-11-09 | 2022-05-12 | 苏州吉玛基因股份有限公司 | 一种gpc1 dna适配体及其应用 |
CN113866407A (zh) * | 2021-12-01 | 2021-12-31 | 上海思路迪医学检验所有限公司 | 一种外泌体her2蛋白的磁免疫化学发光检测试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN105974122B (zh) | 2018-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105974122A (zh) | 一种检测外泌体gpc1蛋白的方法 | |
Sharma et al. | Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma | |
Fernandes et al. | Lab-on-chip cytometry based on magnetoresistive sensors for bacteria detection in milk | |
Beccard et al. | Immune suppressive effects of plasma-derived exosome populations in head and neck cancer | |
Shimoda et al. | Exosome surface glycans reflect osteogenic differentiation of mesenchymal stem cells: profiling by an evanescent field fluorescence-assisted lectin array system | |
Hong et al. | Isolation of biologically active exosomes from plasma of patients with cancer | |
Liu et al. | Advances of single-cell protein analysis | |
Nguyen et al. | Extracellular vesicles from bone marrow-derived mesenchymal stromal cells support ex vivo survival of human antibody secreting cells | |
Peng et al. | Lateral flow immunoassay coupled with copper enhancement for rapid and sensitive SARS-CoV-2 nucleocapsid protein detection | |
Sinha et al. | Proteomic profiling of secreted proteins, exosomes, and microvesicles in cell culture conditioned media | |
Wu et al. | Microfluidic technology for the isolation and analysis of exosomes | |
CN108872564A (zh) | 一种基于外泌体的体外即时检测平台及其检测方法 | |
Lima Moura et al. | Matrix effect in the isolation of breast cancer-derived nanovesicles by immunomagnetic separation and electrochemical immunosensing—a comparative study | |
Zhang et al. | Proteomics analysis of exosomes from patients with active tuberculosis reveals infection profiles and potential biomarkers | |
Lee et al. | Enrichment of circulating tumor cells from whole blood using a microfluidic device for sequential physical and magnetophoretic separations | |
Wu et al. | Magnetic-based enrichment of rare cells from high concentrated blood samples | |
Bardi et al. | Detection of inflammation-related melanoma small extracellular vesicle (sEV) mRNA content using primary melanocyte sEVs as a reference | |
Vinduska et al. | Exosomal surface protein detection with quantum dots and immunomagnetic capture for cancer detection | |
Dittmer et al. | Carcinoma-associated fibroblasts promote growth of Sox2-expressing breast cancer cells | |
Leñero et al. | CD146+ Endometrial-derived mesenchymal stem/stromal cell subpopulation possesses exosomal secretomes with strong immunomodulatory miRNA attributes | |
Gribko et al. | IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells | |
Marcon et al. | DDX6 helicase behavior and protein partners in human adipose tissue-derived stem cells during early adipogenesis and osteogenesis | |
Park et al. | Enhanced luminescent detection of circulating tumor cells by a 3D printed Immunomagnetic concentrator | |
Gao et al. | Offline coupling of asymmetrical flow field-flow fractionation and capillary electrophoresis for separation of extracellular vesicles | |
Pan et al. | Folic acid-modified fluorescent-magnetic nanoparticles for efficient isolation and identification of circulating tumor cells in ovarian cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 310000, room 341, Jin Jun Road, Jianggan District, Hangzhou, Zhejiang, 1114 Applicant after: Huadong medicine (Hangzhou) gene science and Technology Co Ltd Address before: Hangzhou City, Zhejiang province Binjiang District 310000 shore road 688 building 6 room 402 Applicant before: Huadong medicine (Hangzhou) gene science and Technology Co Ltd |
|
CB02 | Change of applicant information | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Xiang Shuanghong Inventor after: Ling Zhiqiang Inventor after: Song Xiaohui Inventor after: Ye Hui Inventor before: Xiang Shuanghong Inventor before: Song Xiaohui Inventor before: Ye Hui |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 310000 room 1114, Jin Jun Road, 341 Shui Xiang Road, Jianggan District, Hangzhou, Zhejiang. Patentee after: Navigation gene technology (Hangzhou) Co., Ltd. Address before: 310000 room 1114, Jin Jun Road, 341 Shui Xiang Road, Jianggan District, Hangzhou, Zhejiang. Patentee before: Huadong medicine (Hangzhou) gene science and Technology Co Ltd |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211216 Address after: 518000 g1316, Lianxing building, building B, Yihua new village, district 46, Haifu community, Xin'an street, Bao'an District, Shenzhen, Guangdong Province Patentee after: Pilot medical technology (Shenzhen) Co.,Ltd. Address before: 310000 room 1114, Jin Jun Road, 341 Shui Xiang Road, Jianggan District, Hangzhou, Zhejiang. Patentee before: PILOT GENE TECHNOLOGIES (HANGZHOU) Co.,Ltd. |
|
TR01 | Transfer of patent right |